1 Market Overview of Meningococcal Conjugate 1.1 Meningococcal Conjugate Market Overview 1.1.1 Meningococcal Conjugate Product Scope 1.1.2 Meningococcal Conjugate Market Status and Outlook 1.2 Global Meningococcal Conjugate Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Meningococcal Conjugate Market Size by Region (2016-2027) 1.4 Global Meningococcal Conjugate Historic Market Size by Region (2016-2021) 1.5 Global Meningococcal Conjugate Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Meningococcal Conjugate Market Size (2016-2027) 1.6.1 North America Meningococcal Conjugate Market Size (2016-2027) 1.6.2 Europe Meningococcal Conjugate Market Size (2016-2027) 1.6.3 Asia-Pacific Meningococcal Conjugate Market Size (2016-2027) 1.6.4 Latin America Meningococcal Conjugate Market Size (2016-2027) 1.6.5 Middle East & Africa Meningococcal Conjugate Market Size (2016-2027) 2 Meningococcal Conjugate Market Overview by Type 2.1 Global Meningococcal Conjugate Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Meningococcal Conjugate Historic Market Size by Type (2016-2021) 2.3 Global Meningococcal Conjugate Forecasted Market Size by Type (2022-2027) 2.4 Menactra 2.5 Menveo 2.6 NeisVac-C 2.7 Nimenrix 2.8 Others 3 Meningococcal Conjugate Market Overview by Application 3.1 Global Meningococcal Conjugate Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Meningococcal Conjugate Historic Market Size by Application (2016-2021) 3.3 Global Meningococcal Conjugate Forecasted Market Size by Application (2022-2027) 3.4 Children 3.5 Preteens or Teens 3.6 Adults 4 Meningococcal Conjugate Competition Analysis by Players 4.1 Global Meningococcal Conjugate Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2020) 4.3 Date of Key Players Enter into Meningococcal Conjugate Market 4.4 Global Top Players Meningococcal Conjugate Headquarters and Area Served 4.5 Key Players Meningococcal Conjugate Product Solution and Service 4.6 Competitive Status 4.6.1 Meningococcal Conjugate Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Sanofi Pasteur 5.1.1 Sanofi Pasteur Profile 5.1.2 Sanofi Pasteur Main Business 5.1.3 Sanofi Pasteur Meningococcal Conjugate Products, Services and Solutions 5.1.4 Sanofi Pasteur Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.1.5 Sanofi Pasteur Recent Developments 5.2 Pfizer 5.2.1 Pfizer Profile 5.2.2 Pfizer Main Business 5.2.3 Pfizer Meningococcal Conjugate Products, Services and Solutions 5.2.4 Pfizer Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.2.5 Pfizer Recent Developments 5.3 Glaxo Smith Kline 5.3.1 Glaxo Smith Kline Profile 5.3.2 Glaxo Smith Kline Main Business 5.3.3 Glaxo Smith Kline Meningococcal Conjugate Products, Services and Solutions 5.3.4 Glaxo Smith Kline Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.3.5 Hualan Biological Engineering Recent Developments 5.4 Hualan Biological Engineering 5.4.1 Hualan Biological Engineering Profile 5.4.2 Hualan Biological Engineering Main Business 5.4.3 Hualan Biological Engineering Meningococcal Conjugate Products, Services and Solutions 5.4.4 Hualan Biological Engineering Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.4.5 Hualan Biological Engineering Recent Developments 5.5 JN International Medical Corporation 5.5.1 JN International Medical Corporation Profile 5.5.2 JN International Medical Corporation Main Business 5.5.3 JN International Medical Corporation Meningococcal Conjugate Products, Services and Solutions 5.5.4 JN International Medical Corporation Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.5.5 JN International Medical Corporation Recent Developments 5.6 Baxter International 5.6.1 Baxter International Profile 5.6.2 Baxter International Main Business 5.6.3 Baxter International Meningococcal Conjugate Products, Services and Solutions 5.6.4 Baxter International Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.6.5 Baxter International Recent Developments 5.7 Merck 5.7.1 Merck Profile 5.7.2 Merck Main Business 5.7.3 Merck Meningococcal Conjugate Products, Services and Solutions 5.7.4 Merck Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.7.5 Merck Recent Developments 5.8 Serum Institute of India 5.8.1 Serum Institute of India Profile 5.8.2 Serum Institute of India Main Business 5.8.3 Serum Institute of India Meningococcal Conjugate Products, Services and Solutions 5.8.4 Serum Institute of India Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.8.5 Serum Institute of India Recent Developments 5.9 Biomed 5.9.1 Biomed Profile 5.9.2 Biomed Main Business 5.9.3 Biomed Meningococcal Conjugate Products, Services and Solutions 5.9.4 Biomed Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.9.5 Biomed Recent Developments 5.10 Novartis 5.10.1 Novartis Profile 5.10.2 Novartis Main Business 5.10.3 Novartis Meningococcal Conjugate Products, Services and Solutions 5.10.4 Novartis Meningococcal Conjugate Revenue (US$ Million) & (2016-2021) 5.10.5 Novartis Recent Developments 6 North America 6.1 North America Meningococcal Conjugate Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Meningococcal Conjugate Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Meningococcal Conjugate Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Meningococcal Conjugate Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Meningococcal Conjugate Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Meningococcal Conjugate Market Dynamics 11.1 Meningococcal Conjugate Industry Trends 11.2 Meningococcal Conjugate Market Drivers 11.3 Meningococcal Conjugate Market Challenges 11.4 Meningococcal Conjugate Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Meningococcal Conjugate Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Meningococcal Conjugate Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Meningococcal Conjugate Market Size Share by Region (2016-2021) Table 4. Global Meningococcal Conjugate Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Meningococcal Conjugate Forecasted Market Size Share by Region (2022-2027) Table 6. Global Meningococcal Conjugate Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Meningococcal Conjugate Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Meningococcal Conjugate Revenue Market Share by Type (2016-2021) Table 9. Global Meningococcal Conjugate Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Meningococcal Conjugate Revenue Market Share by Type (2022-2027) Table 11. Global Meningococcal Conjugate Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Meningococcal Conjugate Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Meningococcal Conjugate Revenue Market Share by Application (2016-2021) Table 14. Global Meningococcal Conjugate Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Meningococcal Conjugate Revenue Market Share by Application (2022-2027) Table 16. Global Meningococcal Conjugate Revenue (US$ Million) by Players (2016-2021) Table 17. Global Meningococcal Conjugate Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Conjugate as of 2020) Table 19. Date of Key Manufacturers Enter into Meningococcal Conjugate Market Table 20. Global Meningococcal Conjugate Top Players Headquarters and Area Served Table 21. Meningococcal Conjugate Product Solution and Service Table 22. Global Meningococcal Conjugate Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Sanofi Pasteur Basic Information List Table 25. Sanofi Pasteur Description and Business Overview Table 26. Sanofi Pasteur Meningococcal Conjugate Products, Services and Solutions Table 27. Revenue (US$ Million) in Meningococcal Conjugate Business of Sanofi Pasteur (2016-2021) Table 28. Sanofi Pasteur Recent Developments Table 29. Pfizer Basic Information List Table 30. Pfizer Description and Business Overview Table 31. Pfizer Meningococcal Conjugate Products, Services and Solutions Table 32. Revenue (US$ Million) in Meningococcal Conjugate Business of Pfizer (2016-2021) Table 33. Pfizer Recent Developments Table 34. Glaxo Smith Kline Basic Information List Table 35. Glaxo Smith Kline Description and Business Overview Table 36. Glaxo Smith Kline Meningococcal Conjugate Products, Services and Solutions Table 37. Revenue (US$ Million) in Meningococcal Conjugate Business of Glaxo Smith Kline (2016-2021) Table 38. Glaxo Smith Kline Recent Developments Table 39. Hualan Biological Engineering Basic Information List Table 40. Hualan Biological Engineering Description and Business Overview Table 41. Hualan Biological Engineering Meningococcal Conjugate Products, Services and Solutions Table 42. Revenue (US$ Million) in Meningococcal Conjugate Business of Hualan Biological Engineering (2016-2021) Table 43. Hualan Biological Engineering Recent Developments Table 44. JN International Medical Corporation Basic Information List Table 45. JN International Medical Corporation Description and Business Overview Table 46. JN International Medical Corporation Meningococcal Conjugate Products, Services and Solutions Table 47. Revenue (US$ Million) in Meningococcal Conjugate Business of JN International Medical Corporation (2016-2021) Table 48. JN International Medical Corporation Recent Developments Table 49. Baxter International Basic Information List Table 50. Baxter International Description and Business Overview Table 51. Baxter International Meningococcal Conjugate Products, Services and Solutions Table 52. Revenue (US$ Million) in Meningococcal Conjugate Business of Baxter International (2016-2021) Table 53. Baxter International Recent Developments Table 54. Merck Basic Information List Table 55. Merck Description and Business Overview Table 56. Merck Meningococcal Conjugate Products, Services and Solutions Table 57. Revenue (US$ Million) in Meningococcal Conjugate Business of Merck (2016-2021) Table 58. Merck Recent Developments Table 59. Serum Institute of India Basic Information List Table 60. Serum Institute of India Description and Business Overview Table 61. Serum Institute of India Meningococcal Conjugate Products, Services and Solutions Table 62. Revenue (US$ Million) in Meningococcal Conjugate Business of Serum Institute of India (2016-2021) Table 63. Serum Institute of India Recent Developments Table 64. Biomed Basic Information List Table 65. Biomed Description and Business Overview Table 66. Biomed Meningococcal Conjugate Products, Services and Solutions Table 67. Revenue (US$ Million) in Meningococcal Conjugate Business of Biomed (2016-2021) Table 68. Biomed Recent Developments Table 69. Novartis Basic Information List Table 70. Novartis Description and Business Overview Table 71. Novartis Meningococcal Conjugate Products, Services and Solutions Table 72. Revenue (US$ Million) in Meningococcal Conjugate Business of Novartis (2016-2021) Table 73. Novartis Recent Developments Table 74. North America Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million) Table 75. North America Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific Meningococcal Conjugate Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific Meningococcal Conjugate Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific Meningococcal Conjugate Market Share by Region (2016-2021) Table 81. Asia-Pacific Meningococcal Conjugate Market Share by Region (2022-2027) Table 82. Latin America Meningococcal Conjugate Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa Meningococcal Conjugate Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa Meningococcal Conjugate Market Size by Country (2022-2027) & (US$ Million) Table 86. Meningococcal Conjugate Market Trends Table 87. Meningococcal Conjugate Market Drivers Table 88. Meningococcal Conjugate Market Challenges Table 89. Meningococcal Conjugate Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global Meningococcal Conjugate Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Meningococcal Conjugate Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Meningococcal Conjugate Market Share by Regions: 2021 VS 2027 Figure 4. Global Meningococcal Conjugate Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Meningococcal Conjugate Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Meningococcal Conjugate Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Meningococcal Conjugate Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Meningococcal Conjugate Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Meningococcal Conjugate Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Meningococcal Conjugate Market Size Share by Type in 2021 & 2027 Figure 11. Menactra Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Menveo Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. NeisVac-C Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Nimenrix Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Global Meningococcal Conjugate Market Size Share by Application in 2021 & 2027 Figure 17. Children Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Preteens or Teens Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Adults Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Meningococcal Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Top 5 and Top 10 Players Meningococcal Conjugate Market Share in 2020 Figure 22. North America Meningococcal Conjugate Market Share by Country (2016-2027) Figure 23. United States Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 24. Canada Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 25. Germany Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 26. France Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 27. U.K. Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 28. Italy Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 29. Russia Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 30. Nordic Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 31. Rest of Europe Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 32. Asia-Pacific Meningococcal Conjugate Market Share by Region (2016-2027) Figure 33. China Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 34. Japan Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 35. South Korea Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 36. Southeast Asia Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 37. India Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 38. Australia Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 39. Rest of Asia-Pacific Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 40. Latin America Meningococcal Conjugate Market Share by Country (2016-2027) Figure 41. Mexico Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 42. Brazil Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 43. Rest of Latin America Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 44. Middle East & Africa Meningococcal Conjugate Market Share by Country (2016-2027) Figure 45. Turkey Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 46. Saudi Arabia Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 47. UAE Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 48. Rest of Middle East & Africa Meningococcal Conjugate Market Size (2016-2027) & (US$ Million) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation

Sanofi Pasteur Pfizer Glaxo Smith Kline Hualan Biological Engineering JN International Medical Corporation Baxter International Merck Serum Institute of India Biomed Novartis